Progyny, Inc. 8-K Filing: Key Disclosure on January 13, 2025

Based on the provided section of the financial report, here are the key extracted pieces of information:
- Filing Information:
- Filing Type: 8-K
- Filing Date: January 13, 2025
- Entity Details:
- Company Name: Progyny, Inc.
- State of Incorporation: Delaware (DE)
- Central Index Key (CIK): 0001551306
- SEC File Number: 001-39100
- EIN: 27-2220139
- Address: 1359 Broadway, New York, NY 10018
- Phone Number: (212) 888-3124
- Securities Information:
- Common Stock Ticker: PGNY
- Exchange: NASDAQ
- Context and Reporting Period:
- Report Context ID: c-1
- Period Start Date: January 13, 2025
- Period End Date: January 13, 2025
Insights:
- The report indicates that Progyny, Inc. is making a significant disclosure via an 8-K filing, which is typically used to announce major events that shareholders should know about.
- The timing of the report suggests that it may relate to events occurring on or around the same date.
- The fact that it is listed on NASDAQ under the ticker PGNY provides insights into its market presence and potential investor interest.
Overall, this filing is part of Progyny, Inc.'s ongoing regulatory obligations, and its implications would depend on the specific events or changes being reported, which are not detailed in this excerpt. Further analysis would require additional context or content from the 8-K filing itself.